Publications
Detailed Information
타미플루의 임상적 처방 : Clinical Use of Tamiflu (Oseltamivir)
Cited 0 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Issue Date
- 2008
- Publisher
- Korean Medical Association = 대한의사협회
- Citation
- J Korean Med Assoc 2008; 51: 757-763
- Keywords
- Oseltamivir ; Influenza ; Avian influenza ; 오셀타미비어 ; 타미플루 ; 인플루엔자 ; 조류인플루엔자
- Abstract
- Oseltamivir (Tamiflu, the trade name) is a neuraminidase inhibitor used for the treatment and prevention of influenza virus infection as well as those of avian influenza infection. The mechanism of action is inhibition of neuraminidase for blocking the release of newly formed virus particles from the infected respiratory epithelial cells and preventing the further spread of the virus. Development of resistance is rare. The adult dose is 75mg (p.o.) b.i.d. for 5 days for treatment of influenza. The adverse drug reactions of oseltamivir are very rare but in children and adolescents careful monitoring is needed.
- ISSN
- 0023-4028
- Language
- Korean
- Files in This Item:
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.